Nemes Rush Group LLC Incyte Corp Transaction History
Nemes Rush Group LLC
- $728 Billion
- Q2 2024
A detailed history of Nemes Rush Group LLC transactions in Incyte Corp stock. As of the latest transaction made, Nemes Rush Group LLC holds 28 shares of INCY stock, worth $2,121. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28
Previous 645
95.66%
Holding current value
$2,121
Previous $36.7 Million
95.38%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding INCY
# of Institutions
627Shares Held
197MCall Options Held
766KPut Options Held
476K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.33 Billion24.77% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.62 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.54 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA15.3MShares$1.16 Billion0.58% of portfolio
-
State Street Corp Boston, MA10.9MShares$822 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $16.8B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...